{
    "url": "https://nationalscreening.blog.gov.uk/2026/01/19/cross-partner-working-on-targeted-screening-uk-nsc-nice-and-his/",
    "title": "Cross-partner working on targeted screening: UK NSC, NICE and HIS",
    "authors": [
        "Carolina Martinelli",
        "Roberta James",
        "Dr Sarah Byron"
    ],
    "categories": [
        "General",
        "UK National Screening Committee"
    ],
    "pub_date": "2026-01-19T13:25:21+00:00",
    "content": [
        {
            "text": "The UK National Screening Committee (UK NSC), the National Institute for Health and Care Excellence (NICE),\u00a0and Health Improvement Scotland (HIS) all work\u00a0on\u00a0the\u00a0early detection\u00a0of health conditions, and their work sometimes overlaps and interacts.\u00a0"
        },
        {
            "text": "For example,\u00a0the UK NSC might assess\u00a0a screening pathway proposal\u00a0while\u00a0NICE separately assesses the diagnostic pathway that uses the same test via a clinical guideline or a health technology evaluation. Or there\u00a0may already be NICE or\u00a0Scottish Intercollegiate Guidelines Network (SIGN)\u00a0guidelines in place\u00a0for\u00a0the\u00a0test.\u00a0The\u00a0FIT (faecal immunochemical test)\u00a0kit used to test\u00a0for bowel cancer is\u00a0one example as it is used both in screening and as a test in general practice to help doctors\u00a0diagnose their patients."
        },
        {
            "text": "The main area where these organisations collaborate and work closely together\u00a0is when considering targeted screening\u00a0topics\u00a0for high-risk groups.\u00a0These topics\u00a0can\u00a0sit at the boundary between clinical guidelines\u00a0(which tell doctors how to care for patients)\u00a0and organised screening programmes\u00a0(which invite healthy people for tests).\u00a0"
        },
        {
            "heading": 2,
            "text": "Chief Medical Officer recommendations"
        },
        {
            "text": "Collaboration between the UK NSC, NICE and HIS supports the Chief Medical Officer's recommendations  that\u00a0UK NSC should:\u00a0"
        },
        {
            "heading": 2,
            "text": "What is targeted screening?"
        },
        {
            "text": "Previously, the UK NSC only considered proposals for population screening programmes, while NICE and HIS considered targeted screening topics for groups at higher risk.\u202f\u00a0Following\u00a0the\u00a0independent review of adult screening programmes in 2019, the\u00a04\u00a0CMOs\u00a0recommended\u00a0UK NSC\u00a0should also cover targeted screening.\u00a0"
        },
        {
            "text": "UK NSC\u00a0defines\u00a0targeted screening as:\u202f\u00a0"
        },
        {
            "text": "A nationally delivered proactive screening programme which aims to improve health outcomes in people with the condition being screened for, among groups of people identified as being at elevated/above average risk of a specific condition. Compared\u00a0to the general population, the people targeted may have higher risk because of lifestyle factors, genetic variants or having another health condition.\u202f\u00a0"
        },
        {
            "heading": 2,
            "text": "How targeted screening differs from clinical care"
        },
        {
            "text": "The UK NSC, NICE and HIS have been working together to clarify where organised targeted screening ends and\u00a0the\u00a0testing\u00a0of\u00a0high-risk groups within clinical guidelines\u00a0begins.\u00a0"
        },
        {
            "text": "Important differences\u00a0between the 2 approaches include:\u00a0"
        },
        {
            "text": "Who is being screened or tested: targeted screening largely focuses on people who feel healthy and have no symptoms. Although they are high-risk individuals, they may not know they are at higher risk of the condition being tested for. People who already have symptoms, are being investigated for a condition, or have a diagnosis should be cared for under clinical management."
        },
        {
            "text": "How people are invited:\u00a0targeted screening programmes\u00a0proactively offer tests to high-risk groups at a national level.\u00a0In\u00a0clinical care,\u00a0patients ask for\u00a0tests\u00a0themselves or are referred by their doctor.\u00a0\u00a0"
        },
        {
            "text": "For example,\u00a0people\u00a0with cirrhosis\u00a0(liver scarring)\u00a0have\u00a0an increased risk of developing liver cancer. Because they already have a\u00a0diagnosis, the\u00a0NHS\u00a0monitors\u00a0them regularly for\u00a0complications\u00a0like\u00a0liver cancer. This\u00a0is\u00a0part of their ongoing care, not\u00a0screening.\u00a0"
        },
        {
            "text": "Being clear about these differences helps\u00a0all 3 organisations\u00a0understand their roles\u00a0and\u00a0deliver the\u00a0best outcomes\u00a0for\u00a0the public.\u00a0"
        },
        {
            "heading": 2,
            "text": "Working together in practice"
        },
        {
            "text": "Arrangements to support our joint working include:\u00a0"
        },
        {
            "heading": 2,
            "text": "Keep up to date"
        },
        {
            "text": "The UK NSC blog provides up to date news from the UK NSC. You can\u202fregister to receive updates\u202fdirect to your inbox, so there is no need to keep checking for new articles. If you have any questions about this blog article, or about the work of the UK NSC, please email\u00a0uknsc@dhsc.gov.uk.\u00a0"
        }
    ]
}